Invention Grant
- Patent Title: Multi-species polynucleotide control sequences
-
Application No.: US14249533Application Date: 2014-04-10
-
Publication No.: US10577611B2Publication Date: 2020-03-03
- Inventor: Marco Alexander Van Den Berg
- Applicant: DSM IP ASSETS B.V.
- Applicant Address: NL
- Assignee: Centrient Pharmaceuticals Netherlands, B.V.
- Current Assignee: Centrient Pharmaceuticals Netherlands, B.V.
- Current Assignee Address: NL
- Agency: McNeely, Hare & War, LLP
- Agent William D. Hare, Esq.
- Priority: EP08158028 20080611
- Main IPC: C12N15/00
- IPC: C12N15/00 ; C07H21/00 ; C12N15/63 ; C12N15/70 ; C12N15/80 ; C12N15/81 ; C12N15/75
Abstract:
The present invention relates to polynucleotide sequences which enable a polynucleotide control sequence, such as a promoter, to direct expression in a wide range of industrially relevant species, both prokaryotes and eukaryotes. When the polynucleotide sequences of the invention are applied in combination with selection marker genes it is possible to perform selectable cloning in a laboratory host and use the same construct in the final host.
Public/Granted literature
- US20150232860A1 MULTI-SPECIES POLYNUCLEOTIDE CONTROL SEQUENCES Public/Granted day:2015-08-20
Information query
IPC分类:
